As of the latest SEC filings, NEKTAR THERAPEUTICS (NKTR) is held by 82 institutional funds. The largest fund shareholder is Fidelity Growth Company Fund (FGCKX), holding an estimated $79,671,968.98 in market value, representing 0.10% of its portfolio.
Funds holding NEKTAR THERAPEUTICS (NKTR)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- NKTR
- CIK:
- 0000906709
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.10% | $79,671,968.98 | 1,155,001 | Feb 28, 2026 | Apr 24, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $61,560,420.00 | 855,600 | Mar 31, 2026 | May 28, 2026 |
|
LADFX
LORD ABBETT DEVELOPING GROWTH FUND INC
|
MF | Independent / Boutique | 1.05% | $23,291,265.44 | 273,886 | Apr 30, 2026 | Jun 29, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.03% | $22,506,319.75 | 312,805 | Mar 31, 2026 | May 28, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.10% | $21,288,193.72 | 308,614 | Feb 28, 2026 | Apr 24, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.08% | $19,277,150.80 | 279,460 | Feb 28, 2026 | Apr 24, 2026 |
|
POAGX
PRIMECAP Odyssey Aggressive Growth Fund
|
MF | Independent / Boutique | 0.22% | $15,172,751.76 | 178,419 | Apr 30, 2026 | Jun 29, 2026 |
|
OSCAX
Invesco Main Street Small Cap Fund
|
MF | Invesco | 0.59% | $13,087,992.80 | 181,904 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.02% | $9,713,763.60 | 140,820 | Feb 28, 2026 | Apr 24, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.04% | $9,022,584.00 | 130,800 | Feb 28, 2026 | Apr 24, 2026 |
|
FFGRX
Emerald Growth Fund
|
MF | Independent / Boutique | 0.63% | $8,905,473.84 | 104,721 | Apr 30, 2026 | Jun 22, 2026 |
|
PGRTX
SmallCap Growth Fund I
|
MF | Independent / Boutique | 0.33% | $7,677,496.24 | 90,281 | Apr 30, 2026 | Jun 25, 2026 |
|
SZCRX
DWS Small Cap Core Fund
|
MF | DWS / Deutsche Bank | 0.62% | $6,475,500.00 | 90,000 | Mar 31, 2026 | May 28, 2026 |
|
XPH
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF
|
ETF | State Street (SPDR) | 1.88% | $5,792,406.70 | 80,506 | Mar 31, 2026 | May 28, 2026 |
|
POGRX
PRIMECAP Odyssey Growth Fund
|
MF | Independent / Boutique | 0.11% | $5,775,491.60 | 67,915 | Apr 30, 2026 | Jun 29, 2026 |
|
IHE
iShares U.S. Pharmaceuticals ETF
|
ETF | BlackRock / iShares | 0.56% | $5,626,777.80 | 78,204 | Mar 31, 2026 | May 22, 2026 |
|
PRFZ
Invesco RAFI US 1500 Small-Mid ETF
|
ETF | Invesco | 0.19% | $5,364,408.24 | 63,081 | Apr 30, 2026 | Jun 26, 2026 |
|
VHCIX
VANGUARD HEALTH CARE INDEX FUND
|
ETF | Vanguard | 0.02% | $5,020,916.24 | 72,788 | Feb 28, 2026 | Apr 28, 2026 |
|
LFMGX
Lord Abbett Micro-Cap Growth Fund
|
MF | Independent / Boutique | 1.77% | $3,608,332.24 | 42,431 | Apr 30, 2026 | Jun 29, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $3,473,143.00 | 50,350 | Feb 28, 2026 | Apr 24, 2026 |
|
LFSC
F/m Emerald Life Sciences Innovation ETF
|
ETF | Independent / Boutique | 3.61% | $3,456,863.72 | 50,114 | Feb 28, 2026 | Apr 28, 2026 |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
ETF | Invesco | 2.57% | $3,109,912.80 | 36,570 | Apr 30, 2026 | Jun 26, 2026 |
|
MSCDX
MassMutual Small Cap Opportunities Fund
|
MF | Independent / Boutique | 0.59% | $3,024,562.15 | 42,037 | Mar 31, 2026 | May 27, 2026 |
|
RTSSX
Tax-Managed U.S. Mid & Small Cap Fund
|
MF | Russell Investments | 0.14% | $2,911,684.56 | 34,239 | Apr 30, 2026 | Jun 22, 2026 |
|
ITOT
iShares Core S&P Total U.S. Stock Market ETF
|
ETF | BlackRock / iShares | 0.00% | $2,740,575.50 | 38,090 | Mar 31, 2026 | May 28, 2026 |
Advertisement (320x50)